Samcro Hyosung Adilestari PT Tbk

Samcro Hyosung Adilestari PT Tbk has a market capitalization of 260,187,185,925 IDR, with a market price of 75 IDR per share. The company has 3,469,162,479 basic and diluted shares outstanding, indicating no dilution from share-based compensation or convertible instruments [doc:HA-latest]. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents [doc:HA-latest]. The company operates in the Textiles & Leather Goods industry, where key performance indicators include gross margin, operating margin, and return on invested capital (ROIC). While specific profitability metrics are not available in the input data, the industry typically emphasizes cost control and production efficiency to maintain margins amid fluctuating raw material prices [doc:verified market data]. Samcro Hyosung Adilestari PT Tbk exports its products to a diverse set of countries, including Canada, Italy, Spain, and China, indicating a global customer base. The company's revenue is not disclosed by segment or geography, but its product lines span multiple applications, including gloves, footwear, and medical equipment, suggesting a diversified revenue stream [doc:HA-latest]. The company's growth trajectory is not quantified in the input data, but its presence in multiple international markets and a broad product portfolio may support long-term expansion. The absence of historical revenue data limits the ability to assess growth rates or market share trends [doc:HA-latest]. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and the absence of going-concern language in source documents. The company is also exposed to global supply chain disruptions and currency fluctuations, given its international operations. Dilution risk is currently low, as basic and diluted shares are equal [doc:HA-latest]. Recent events and filings are not detailed in the input data, but the company's operations are subject to regulatory and geopolitical risks, particularly in its export markets. The absence of disclosed capital expenditures or R&D investments suggests a focus on operational efficiency rather than innovation [doc:HA-latest].